Chemotherapy News and Research

Latest Chemotherapy News and Research

No evidence related to transferability of biomarker tests for decision-making on chemotherapy for breast cancer

Following a benefit assessment in 2016 and an addendum in 2018, the German Institute for Quality and Efficiency in Health Care has again examined biomarker-based tests for women with primary breast cancer.

7 Mar 2020

Newly identified genetic signatures in common pediatric cancer pave way for precision medicine

Researchers with Nemours Children's Health System utilized Next Generation Sequencing (NGS) to more precisely identify genomic characteristics of leukemias in children, the most common childhood cancer.

5 Mar 2020

AI helps reveal apparent cellular distinctions between black and white cancer patients

Scientists at Case Western Reserve University are using Artificial Intelligence (AI) to reveal apparent cellular distinctions between black and white cancer patients, while also exploring potential racial bias in the rapidly developing field of AI.

5 Mar 2020

Study provides new evidence about optimal way to treat BRCA carriers with breast cancer

Commonly known as the breast cancer genes, the BRCA gene family plays a role in repairing damaged DNA. Inherited mutations in the genes BRCA1 or BRCA2 raise the risk of developing breast, ovarian, prostate and other cancers.

5 Mar 2020

A new, promising method for developing drugs that target, block macropinocytosis

With drug resistance a major challenge in the fight against cancer, a discovery by University of California, Irvine biologists could offer new approaches to overcoming the obstacle.

3 Mar 2020

Inhibiting specific protein could make radiation therapy for colon cancer more effective

Researchers at Washington University School of Medicine in St. Louis appear to have discovered a way to make radiation therapy for colorectal cancer more effective by inhibiting a protein found in cancer cells in the gut.

3 Mar 2020

Subpopulations of leukemic cells present at diagnosis can cause relapse in children with ALL

Scientists at St. Jude Children's Research Hospital and Princess Margaret Cancer Centre in Toronto, Canada, have reported that subpopulations of leukemic cells present at diagnosis can cause relapse in children with acute lymphoblastic leukemia.

3 Mar 2020

Density of immune cells could accurately predict survival in patients with stage III colon cancer

The density of immune cells, called tumor infiltrating lymphocytes, when combined with analysis of tumor budding may serve as a method to more accurately predict survival in patients with stage III colon cancer.

3 Mar 2020

NYU Abu Dhabi researchers develop nanocarrier for more effective cancer drug delivery

A team of researchers at NYU Abu Dhabi has developed a biocompatible, biodegradable, and economical nanocarrier for safer and more effective delivery of anticancer drugs.

3 Mar 2020

Maine voters consider U-turn on vaccine exemptions

As Mainers head to the polls on Super Tuesday for the presidential primary, they also will decide another issue: vaccine requirements. A statewide referendum asks if voters want to overturn a new law that eliminates religious and philosophical exemptions for childhood vaccines.

3 Mar 2020

Targeted therapy may increase overall survival in patients with pancreatic cancer

Results from 46 patients given treatments that target specific molecular changes in tumor cells suggest that these therapies could help patients with pancreatic cancer whose tumors harbor those changes survive an extra year.

2 Mar 2020

Research shows how physical cues drive cell migration, cancer metastasis, and treatment

Cancer cells are a product of their environment. The surrounding cells, extracellular matrix, and other features influence disease progression and spread of cancer cells to other parts of the body.

28 Feb 2020

Two Wake Forest Baptist scientists receive $1.5 million for cancer research

Two scientists from Wake Forest School of Medicine, part of Wake Forest Baptist Health, have received a total of $1.5 million in research funding from the American Cancer Society to study new chemotherapy and immunotherapy treatments for cancer.

28 Feb 2020

New discovery may be useful for developing novel cancer treatments

Researchers from the University of Copenhagen have discovered that our cells replicate their DNA much more loosely than previously thought.

28 Feb 2020

EHRA 2020: Latest practice-changing research in heart rhythm disorders

Get ready for the latest practice-changing research in heart rhythm disorders: presented at EHRA 2020, a scientific congress of the European Society of Cardiology.

27 Feb 2020

Combination of radiation and immunotherapy shows promise for advanced head and neck cancers

A new phase II trial finds that a combination of radiation therapy and immunotherapy led to encouraging survival outcomes and acceptable toxicity for patients with locally advanced head and neck squamous cell carcinoma

27 Feb 2020

Drug used for breast, renal cancers may provide survival benefit for patients with head and neck cancers

A targeted therapy drug used for breast and kidney cancers may also extend progression-free survival for patients with advanced head and neck cancer who are at high risk for recurrence after standard treatment.

27 Feb 2020

NTHU research team develops new treatment for cancer

A research team led by Dr. Yunching Chen and Tsai-Te Lu of National Tsing Hua University have recently developed a new treatment for cancer, in which blood vessels within malignant tumors are normalized by injecting a specially developed nanodelivery system for nitric oxide (NanoNO), which also facilitates the delivery of cancer drugs and immunocytes into the tumor.

27 Feb 2020

Study reveals the effects of pre-surgical chemotherapy on breast cancer genome

Results from one of the first studies to determine the effects of pre-surgical, or neoadjuvant, chemotherapy on the breast cancer genome offer up two key insights.

26 Feb 2020

Biomarkers in blood samples can predict clinical response to immunotherapy in metastatic NSCLC

Non-small cell lung cancer patients with higher measures of tumor mutations that show up in a blood test generally have a better clinical response to PD-1-based immunotherapy treatments than patients with a lower measure of mutations.

26 Feb 2020

Chemotherapy News and Research

Latest Chemotherapy News and Research

No evidence related to transferability of biomarker tests for decision-making on chemotherapy for breast cancer

Newly identified genetic signatures in common pediatric cancer pave way for precision medicine

AI helps reveal apparent cellular distinctions between black and white cancer patients

Study provides new evidence about optimal way to treat BRCA carriers with breast cancer

A new, promising method for developing drugs that target, block macropinocytosis

Inhibiting specific protein could make radiation therapy for colon cancer more effective

Subpopulations of leukemic cells present at diagnosis can cause relapse in children with ALL

Density of immune cells could accurately predict survival in patients with stage III colon cancer

NYU Abu Dhabi researchers develop nanocarrier for more effective cancer drug delivery

Maine voters consider U-turn on vaccine exemptions

Targeted therapy may increase overall survival in patients with pancreatic cancer

Research shows how physical cues drive cell migration, cancer metastasis, and treatment

Two Wake Forest Baptist scientists receive $1.5 million for cancer research

New discovery may be useful for developing novel cancer treatments

EHRA 2020: Latest practice-changing research in heart rhythm disorders

Combination of radiation and immunotherapy shows promise for advanced head and neck cancers

Drug used for breast, renal cancers may provide survival benefit for patients with head and neck cancers

NTHU research team develops new treatment for cancer

Study reveals the effects of pre-surgical chemotherapy on breast cancer genome

Biomarkers in blood samples can predict clinical response to immunotherapy in metastatic NSCLC

Cancer Research - Second Edition eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Chemotherapy News and Research

Latest Chemotherapy News and Research

Cancer Research - Second Edition eBook

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

How cohesin mechanics and nanotracker tech are redefining DNA research

Newsletters you may be interested in